Literature DB >> 22456357

Deferoxamine enhances the vascular response of bone regeneration in mandibular distraction osteogenesis.

Alexis Donneys1, Aaron S Farberg, Catherine N Tchanque-Fossuo, Sagar S Deshpande, Steven R Buchman.   

Abstract

BACKGROUND: Bone regeneration during distraction osteogenesis is intricately associated with an enhanced vascular response. Augmenting this response may offer considerable clinical advantages such as optimizing the quality of regenerate formation, decreasing lengthy consolidation periods, or increasing regenerate size and distance. Using deferoxamine, an angiogenic transcriptional activator, the authors posit that substantial increases in vascular volume beyond the normal response to mechanical distraction can be quantified with micro-computed tomography after vessel perfusion during mandibular distraction osteogenesis.
METHODS: Two groups of Sprague-Dawley rats (n = 12) underwent external fixator placement, mandibular osteotomy, and 5.1-mm distraction. During distraction, the experimental group (n = 6) was treated with deferoxamine injections into the distraction gap. After consolidation, the animals were perfused and imaged with micro-computed tomography. Vascular radiomorphometrics were calculated and statistical comparison was conducted with the independent samples t test. A value of p ≤ 0.05 was considered statistically significant.
RESULTS: A 40 percent statistically significant increase in the number of vessels (0.82 vessels/mm versus 1.15 vessels/mm; p < 0.012) and a complementary decrease in the space between vessels (1.18 mm versus 0.86 mm; p < 0.012) were calculated in the experimental regenerate when compared with controls. This robust increase in vascularity could also be readily observed with micro-computed tomographic image reconstruction. Gross examination revealed a denser regenerate in the deferoxamine-injected group that is clearly illustrated with Faxitron radiography.
CONCLUSION: The authors' study quantifies the ability of deferoxamine to augment the vascular response of mandibular distraction osteogenesis and establishes correlations between this therapeutic enrichment and enhanced regenerate formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456357      PMCID: PMC4535714          DOI: 10.1097/PRS.0b013e31824422f2

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  13 in total

1.  Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.

Authors:  Alexis Donneys; Noah S Nelson; Joseph E Perosky; Yekaterina Polyatskaya; Jose J Rodriguez; Christian Figueredo; Cheyenne A Vasseli; Hannah C Ratliff; Sagar S Deshpande; Kenneth M Kozloff; Steven R Buchman
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

2.  Topical Deferoxamine Alleviates Skin Injury and Normalizes Atomic Force Microscopy Patterns Following Radiation in a Murine Breast Reconstruction Model.

Authors:  Alicia E Snider; Jeremy V Lynn; Kevin M Urlaub; Alexis Donneys; Yekaterina Polyatskaya; Noah S Nelson; Russell E Ettinger; Geoffrey C Gurtner; Mark M Banaszak Holl; Steven R Buchman
Journal:  Ann Plast Surg       Date:  2018-11       Impact factor: 1.539

3.  Clinical Use of Deferoxamine in Distraction Osteogenesis of Irradiated Bone.

Authors:  Arash Momeni; Scott Rapp; Alexis Donneys; Steven R Buchman; Derrick C Wan
Journal:  J Craniofac Surg       Date:  2016-06       Impact factor: 1.046

Review 4.  Current concepts of bone tissue engineering for craniofacial bone defect repair.

Authors:  Brian Alan Fishero; Nikita Kohli; Anusuya Das; John Jared Christophel; Quanjun Cui
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-18

Review 5.  Application of chemical factors for acceleration of consolidation phase of the distraction osteogenesis: a scoping review.

Authors:  Sadra Mohaghegh; Fatemeh Alirezaei; Nima Ahmadi; Farnaz Kouhestani; Saeed Reza Motamedian
Journal:  Oral Maxillofac Surg       Date:  2022-07-19

6.  Translational treatment paradigm for managing non-unions secondary to radiation injury utilizing adipose derived stem cells and angiogenic therapy.

Authors:  Alexis Donneys; Jordan T Blough; Noah S Nelson; Joseph E Perosky; Sagar S Deshpande; Stephen Y Kang; Peter A Felice; Christian Figueredo; Jonathan R Peterson; Kenneth M Kozloff; Benjamin Levi; Douglas B Chepeha; Steven R Buchman
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

7.  Deferoxamine expedites consolidation during mandibular distraction osteogenesis.

Authors:  Alexis Donneys; Sagar S Deshpande; Catherine N Tchanque-Fossuo; Kelsey L Johnson; Jordan T Blough; Joseph E Perosky; Kenneth M Kozloff; Peter A Felice; Noah S Nelson; Aaron S Farberg; Benjamin Levi; Steven R Buchman
Journal:  Bone       Date:  2013-04-15       Impact factor: 4.398

8.  Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy.

Authors:  Alexis Donneys; Daniela M Weiss; Sagar S Deshpande; Salman Ahsan; Catherine N Tchanque-Fossuo; Deniz Sarhaddi; Benjamin Levi; Steven A Goldstein; Steven R Buchman
Journal:  Bone       Date:  2012-10-18       Impact factor: 4.398

9.  Deferoxamine to Minimize Fibrosis During Radiation Therapy.

Authors:  Ruth Tevlin; Michael T Longaker; Derrick C Wan
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-07-26       Impact factor: 4.947

10.  Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice.

Authors:  Liang Wang; Peng Jia; Yu Shan; Yanming Hao; Xiao Wang; Yu Jiang; Ye Yuan; Qiaoqiao Du; Hui Zhang; Fan Yang; Wen Zhang; Mao Sheng; Youjia Xu
Journal:  Mol Med Rep       Date:  2017-09-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.